Cameroon vs Peru: Access to anti-retroviral drugs, male
Cameroon
79.0%
in 2024
Peru
79.0%
in 2024
Cameroon rank
49th
Peru rank
49th
Access to anti-retroviral drugs, male over time
- Cameroon
- Peru
How they compare
Cameroon currently reports 79.0% against 79.0% in Peru, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Peru ahead.
Cameroon ranks 49th and Peru ranks 49th of 141 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 6.2% | 1.5% | Peru |
| 2010s | 26.0% | 43.1% | 17.1% | Peru |
| 2020s | 68.2% | 74.4% | 6.2% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cameroon or Peru?
- Cameroon, at 79.0% against 79.0% in Peru as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cameroon and Peru?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Peru?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Peru rank globally for access to anti-retroviral drugs, male?
- Cameroon ranks 49th and Peru ranks 49th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.